alzheimer_s_disease_biomarkers

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
alzheimer_s_disease_biomarkers [2020/10/23 11:26]
administrador
alzheimer_s_disease_biomarkers [2020/10/23 11:27] (current)
administrador
Line 1: Line 1:
 ====== Alzheimer's disease biomarkers ====== ====== Alzheimer's disease biomarkers ======
  
-Current diagnosis of [[Alzheimer's disease]] relies largely on documenting [[mild cognitive impairment]], at which point, Alzheimer's has already caused severe [[brain]] [[damage]]. +Current diagnosis of [[Alzheimer's disease]] relies largely on documenting mild [[cognitive]] impairment, at which point, Alzheimer's has already caused severe [[brain]] [[damage]]. 
  
 Several potential biomarkers are being studied for their ability to indicate early stages of Alzheimer's disease. Examples being studied include beta-amyloid and [[tau protein]] levels in [[cerebrospinal fluid]] (CSF) and brain changes detectable by imaging. Recent research suggests that these indicators may change at different stages of the disease process. Several potential biomarkers are being studied for their ability to indicate early stages of Alzheimer's disease. Examples being studied include beta-amyloid and [[tau protein]] levels in [[cerebrospinal fluid]] (CSF) and brain changes detectable by imaging. Recent research suggests that these indicators may change at different stages of the disease process.
  • alzheimer_s_disease_biomarkers.txt
  • Last modified: 2020/10/23 11:27
  • by administrador